Mark Wilson became the first patient in Nebraska to receive a Vivistim implant, a new treatment that could help stroke patients make a better recovery.
With an end-of-week green light from the FDA, Rocket Pharmaceuticals has officially broken into commercial orbit. Still, the company is taking a more measured approach for the launch of its new gene ...
GA, UNITED STATES, March 16, 2026 /EINPresswire.com/ — Hypertrophic scars remain one of the most persistent challenges in wound healing, often resulting in ...
NEW YORK, March 17, 2026 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering allogeneic invariant natural killer T (iNKT) cell therapies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results